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Abstract
Background: Respiratory syncytial virus (RSV) infection is an important cause of hospitalization in previously healthy
infants. Immunological mechanisms predisposing infants to severe disease are poorly understood. Early biomarkers
for disease severity may assist clinical decisions. We investigated T-cell receptor excision circles (TREC), episomal DNA
made during thymic T-cell receptor rearrangement, and a marker for thymus activity, both during disease and in
neonatal screening cards as a risk factor for RSV disease severity.
Methods: One hundred thirteen patients hospitalized with RSV infection <12 months of age, grouped by disease
severity, were available for this investigation, in which we conducted both a prospective and a case-control study.
The prospective study included 47 RSV positive infants (mild n = 13, moderate n = 10, severe n = 24). TREC counts
were determined by PCR of DNA extracted from EDTA-blood collected on hospitalization, and corrected for lymphocytes
using ANCOVA. The case-control study included 85 newborns who later in infancy became RSV positive (mild n = 32,
moderate n = 24, severe n = 29) and 47 newborns who never developed RSV disease as healthy controls included from
health centres in the same catchment area. TRECs were measured using DNA extracted from dry blood spots from stored
neonatal screening cards, followed by PCR. Student’s T-test compared patients with controls, ANOVA compared disease
severity groups.
Results: During RSV infection patients in the severe disease group had significantly lower (p = 0.017) TREC/200 μL blood
compared to the other two disease groups, after correction for lymphocyte count. Newborn TREC levels, were
significantly higher in RSV patients compared to controls (p < 0.0001). No significant differences in TREC copies
at birth were found between disease severities.
Conclusion: During acute RSV infection a lower number of TREC is found in the severe disease group. TREC has
potential as an immunological marker for severe RSV infection. Higher neonatal TREC counts indicate that infants later
presenting with severe RSV do not have reduced thymic activity at birth and probably no congenital T-cell defect.
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Background
Respiratory syncytial virus (RSV) infection occurs in
annual winter epidemics. Almost all children are exposed
before two years of age [1, 2]. Clinical conditions include
mild upper respiratory tract infection, bronchiolitis,
pneumonia and respiratory failure. 22–31/1000 infants
under one year of age [2, 3] are hospitalized and may
require supportive treatment including oxygen, fluids,
continuous positive airway pressure (CPAP) and in some
severe cases mechanical ventilation [1].
Innate immune cells responding to RSV activate naïve
T-cells [2], which have a critical role in termination of an
acute RSV infection. The thymus has important biological
roles in the generation of T-cells from precursor bone
marrow derived cells. T-cell receptor excision circles
(TRECs) are circular pieces of DNA generated during the
rearrangement of variable V, D, and J segments of T-cell
receptor (TCR) genes in the thymus [4, 5]. TREC is an
accurate measure of thymic function [6] because it
arises in the late phase of thymocyte maturation [4, 5].
It can be used to estimate thymic activity in peripheral
blood because intrathymic and peripheral TREC values
are correlated [7]. In the case of T-cell lymphopenia
very low or undetectable TREC levels will be found in
peripheral blood, this reflects the lack of T-cells produced
by the thymus [4]. TRECs do not replicate during cell
division, and are therefore more abundant in naïve T-cells
that have recently emigrated from the thymus. Over 70%
of rearranged α/β T-cell receptors form a circular DNA
TREC [4]. Newborns have high TREC levels that decline
with increasing age together with a peripheral T-cell
expansion [8].
In the first part of this study we investigated thymus
activity in RSV disease using EDTA blood samples col-
lected during a prospective study of RSV bronchiolitis.
The results indicated low TREC counts in the severe
disease group. Furthermore, to determine if these patients
had low thymus activity (TRECs) already from birth, we
quantified TRECs in dried blood spot (DBS) of newborn
screening (NBS) filter cards and compared them to con-
trols. Other thymic markers such as TCR delta chain
(TCRD) and the amount of regulatory T cells (Tregs) are
also well correlated with thymic capacity [9]; we decided
to use TREC because the method has been established in
our laboratory as a screening tool for patients with severe
combined immunodeficiency.
The aim of this study was to investigate thymus activity
in patients with RSV infection, both at birth in those who
later developed RSV disease and during disease, and the
impact of thymus activity on disease severity.
Methods
During the RSV season in Akershus and North Oslo,
Norway, from January – March 2011, infants < 12 months
of age with respiratory tract infection examined at the
paediatric emergency unit, Akershus University Hospital
were considered for inclusion in a study of nasal mucosa
miRNA expression [10]. One hundred and thirteen
patients and 102 controls were recruited. Clinical data
and blood samples from patients were collected for later
analysis. The controls were recruited from the local
health centres.
In our prospective study EDTA blood available in 47
of the included patients were used. The patients were
grouped into mild, moderate and severe disease based
on clinical data. On inclusion, patients were assessed by
the treating paediatrician for respiratory distress using
the validated Respiratory Distress Assessment Instru-
ment (RDAI) [11] . The RDAI assesses retractions (max
9 points), wheeze (max 8 points) and changes in respira-
tory rate. A modified RDAI (m-RDAI) was developed to
permit a single observation of respiratory rate and is
described further in Table 1 [10]. Children receiving
oxygen or fluid supplement, continuous positive airways
pressure (CPAP) or mechanical ventilation was classified
with severe disease. Children not admitted were classified
with mild disease. Children admitted but who did not re-
ceive oxygen, fluids, CPAP or mechanical ventilation were
classified with moderate disease if they had an m-RDAI
9–25, and with mild disease if they had an m-RDAI 0–8.
Clinical characteristics and treatments given are provided
in Table 2.
To investigate TREC numbers at birth dried blood on
filter cards taken as part of the national neonatal screening
program was used. All 113 RSV-positive patients and 102
control infants were invited to participate in a case-con-
trol study, 85 patients and 47 controls consented. Let-
ters of invitation, consent forms and a questionnaire
were sent autumn 2014. Controls were asked about
chronic diseases, if they had ever been admitted to hos-
pital or been positive for RSV. Patients and controls with
congenital heart disease, chronic lung disease including
treated asthma or bronchopulmonary dysplasia, neuro-
logical disease, Down’s syndrome, hypotonia, failure to
thrive, born <34 weeks gestation, or with other specific
conditions associated with more severe disease were
excluded.
Sample collection and virus detection
Infants with suspected RSV infection underwent deep
nasal aspiration. Two ml viral transport medium was
then suctioned through the suction tube into the sample
collection tubes. A rapid antigen test (Abbott TestPack
RSV, Abbott laboratories) [12] and/ or multiplex quanti-
tative PCR (qPCR) (in-house test) at the Department of
Microbiology, Akershus University Hospital confirmed
RSV infection. Blood was collected in 2 ml EDTA tubes
on inclusion and stored at -80 °C. Automated differential
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white blood cell count was performed. Stored blood
samples on filter cards from the National NBS Diagnostic
Biobank (Oslo University Hospital, Norway) were col-
lected 3 days after birth and stored between -20° and
-25 °C. Previous reports demonstrate no significant dif-
ference in TREC values between new and old filter
cards [13, 14].
DNA-extraction
Genomic DNA from 200 μl blood was extracted in 100 μl
elution solution using the Blood DNA kit (Omega-Biotek,
USA) protocol. DNA concentration was measured
using Nanodrop (Spectrophotometer ND-1000, USA).
A 3.2 mm punch from neonatal screening filter cards
was washed with 150 μl DNA Elution solution Qiagen
(S2) at 60 °C whilst shaking at 1000 rpm for 10 min in
a thermo shaker (TS-100 Biosan, EU) followed by DNA
elution in 100 μl S2 at 99.5 °C with continuous shaking
at 1000 rpm for 30 min.
Quantitative PCR
DNA extracts were analysed by qPCR on an ABI Via7
(Applied Biosystems), as previously described [15]. The
DNA extract from dried blood spots (DBS) was investi-
gated using the same protocol, modified by using quanta
perfecta mastermix (QuantaBio, Beverly, MA).
A TREC plasmid, generated by Douek [4], was pro-
vided by the Medical College of Wisconsin, and used to
construct the standard curve ranging from 40 000 copies
to 10 copies with TREC plasmid concentrations diluted
in dilution solution (Qiagen Generation solution 2 con-
taining tRNA 100 ng/μl). Nanodrop (Spectrophotometer
ND-1000) was used to measure TREC plasmid concen-
tration. We used β-actin as housekeeping gene to assure
adequate DNA extraction. All analyzed qPCR assays had
similar slopes and R2 values > 0.99.
Statistical analysis
IBM SPSS version 22.0 was used for statistical analyses.
Clinical characteristics were compared between mild,
moderate and severe disease groups using One-way
ANOVA, Kruskal-Wallis or Chi-squared tests as appro-
priate. Length of hospital stay and measures of respira-
tory distress were compared between moderate and
severe disease groups using Mann-Whitney or Fisher’s
exact tests. One-way ANOVA was used to compare
TREC copies and lymphocyte counts between severity
groups during RSV disease, with post-hoc analysis using
least significant difference (LSD). Univariate linear regres-
sion analysis was used to compare TREC copies with
lymphocyte counts. Analysis of covariance (ANCOVA) is
a general linear model that allows comparison of a con-
tinuous variable between groups whilst adjusting for
other continuous variables. ANCOVA was used to
adjust for effects of lymphocyte count when comparing
TREC counts between disease severity groups. Esti-
mated marginal means and 95% confidence interval for
TREC copies by group were extracted from the
ANCOVA.
TREC copies at birth were not normally distributed
and were log transformed prior to statistical analysis.
Student’s T-test was used to compare controls and RSV
positive patients. One-way ANOVA was used to com-
pare TREC copies between controls and the three
severity groups with post-hoc testing using Dunnett’s
test, in which each severity group was compared to the
control group.
Table 1 Modified respiratory distress assessment Instrument (m-RDAI)
Points 0 1 2 3 4
Wheeze
Expiration No End-Expiratory ½ of inspiration ¾ of inspiration Whole expiration
Inspiration No Partly Whole inspiration
Location None ≤2 of 4 lung fields ≥ 3 of 4 lung fields
Retractions
Suprasternal No Mild Moderate Significant
Intercostal No Mild Moderate Significant
Subcostal No Mild Moderate Significant
Respiratory rate Upper limit for normal
respiratory rate
Points
Age < 1 month 50/ min 1 point for each increment
of 5 breaths/minute above
normal, max. 8 pointsAge 1–5 months 40/ min
Age 6–11 months 30/ min
Maximum score for wheeze - 8 points; for retractions – 9 points; for respiratory rate – 8 points. Thus RR, retractions and wheeze are equally weighted. Maximum m-RDAI
score is 25 points. Adapted from [11]. Age-associated limits for respiratory rate (RR) were set according to the literature and clinical experience. Example - a 3-month old
child with a respiratory rate of 62 receives 5 points for Respiratory rate (62–40 = 22; 22/5 = 4.4; round up to 5)
Gul et al. BMC Infectious Diseases  (2017) 17:18 Page 3 of 8
Results
TREC in RSV positive children during acute illness
EDTA blood was available for 47 patients and lymphocyte
counts for 64. Significant correlation between TREC
copies and disease severity was found (p = 0.007). Mean
TREC copies in mild disease group was 29 x 103 TREC/
200 μl (95% CI 15–43 x 103 TREC/200 μl), moderate
group 40 x 103 TREC/200 μl (95% CI 24–57 x 103 TREC/
200 μl), and severe disease group 22 x 103 TREC/200 μl
(95% CI 10–33 x 103 TREC/200 μl). Reduced TREC
copies were identified in the severe disease group com-
pared to mild and moderate (p = 0.038 and p = 0.003,
respectively). Lymphocyte counts showed a similar pat-
tern, but was not statistically significant (p = 0.21). Since
TREC copies were strongly correlated to lymphocyte
count (p = 0.00001; R2 = 0.371), we wished to exclude
lymphocyte count as a confounder. On analysis using
ANCOVA, disease severity maintained a significant effect
Table 2 Clinical characteristics of RSV-positive infants, categorised by disease severity
Mild Moderate Severe Sig.
Total number of patients 37 25 40
TREC during RSV infection, number of patients 13 10 24
TREC in neonatal screening cards, number of patients 32 24 29
Age when RSV diseased - months, median (IQR) 3 (1–6) 3 (1–5.5) 2 (1–4) p = 0.4a
Male gender, number (%) 14 (38%) 14 (56%) 17 (43%) p = 0.4b
Weight - grams, mean (SD) 6522 (2277) 6748 (1935) 5974 (2065) p = 0.4c
Duration of symptoms at admission - days, median (IQR) 4 (3–5.25) 4 (3.5–5) 4 (3–5) p = 0.9a
Admission, number (%) 20 (54%) 25 (100%) 40 (100%)
Length of stay, median (IQR) 1 (0–1) 1 (1–3) 4 (2.5–5.5) p < 0.0001d
Length of stay > 3 days, number (%) 1 (3%) 3 (12%) 24 (62%) p < 0.0001e
Respiratory distress
SpO2 - % on admission, mean (SD) 97.4 (2.6) 97.9 (2.3) 94.7 (4.5) p < 0.0001
c
Respiratory rate /min on admission, mean (SD) 49 (12) 58 (12) 57 (10) p = 0.002c
Respiratory rate score (max. 8), median (IQR) 2 (0.75–4.25) 4 (2.5–6) 4 (2–6) p = 0.007a
p = 0.4d
Retraction score (max. 9), median (IQR) 1 (0–2) 4 (2.25–6) 2 (1–4) p < 0.0001a
p = 0.003d
Wheeze score (max. 8), median (IQR) 0 (0–3) 5 (4–6) 2 (0–4) p < 0.0001a
p = 0.0002d
m-RDAI, median (IQR) 6 (2–8) 13 (10.5–16) 8 (6–11) p < 0.0001a
p < 0.0001d
Treatments
Fluid supplement, number (%) 16 (40%)
Intravenous fluids, number (%) 4 (10%)
Nasogastric fluid, number (%) 14 (35%)
Oxygen supplement, number (%) 35 (88%)
CPAP, number (%) 4 (10%)
Respirator, number (%) 0 (0%)
Of 113 patients available for the study, 92 were included. Fourtyseven had TREC analysed during acute RSV infection, 85 had TREC analysed in neonatal screening
cards. Values presented and statistical tests are performed using the total number of RSV positive children included in this study. Analyses show similar results
when including only infants studied in the analysis of TREC during RSV infection, or only infants studied in the analysis of neonatal TREC (details not presented). There
were no significant differences in age, weight, gender or duration of symptoms between disease severity groups. The severe disease group had a lower SpO2
on admission, but had less respiratory distress than the moderate group, as measured by the m-RDAI. The retraction and wheeze scores in particular contributed to this
difference. Length of hospital stay increased with increasing severity. The most common treatment for children with severe disease was oxygen supplementation. Only




dMann-Whitney test, comparing moderate and severe disease subgroups
eFisher’s exact test, comparing moderate and severe disease subgroups
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on TREC copies (F = 4.6; p = 0.017; partial Et2 =
0.189), as did lymphocyte count (F = 19; p = 0.00009;
partial Eta2 = 0.328) and the corrected model h F = 12.5;
p = 0.000007; Partial Eta2 = 0.49. Post-hoc testing in this
adjusted model confirmed reduced TREC in the severe
disease group compared to mild and moderate groups
(p = 0.07 and 0.007, respectively). Results are shown
in Fig. 1.
TREC in neonatal DBS filter cards from patients and
controls
Eightyfive/113 (75%) RSV-positive (mild n = 32, moderate
n = 24, severe n = 29) and 60/102 (59%) controls con-
sented to the neonatal filter card study. Fortyseven (78%)
controls were eligible for inclusion. There were signifi-
cantly higher TREC copies in neonatal filtercards of RSV
positive patients (p < 0.0001, Student’s T-test); mean TREC
copies 551 TREC/μl in RSV positive patients (95% CI
493–609 TREC/μl) compared to 388 TREC/μl in controls
(95% CI 329–426 TREC/ μl). There was no significant
difference between disease subgroups. Significantly higher
TREC copies were found when those who later developed
mild and severe disease subgroups were compared to
controls (p < 0.0001, p = 0.012, respectively). Results are
shown in Fig. 2.
Discussion
We found that children assessed at the hospital emer-
gency ward for RSV infection have lower TREC counts
in whole blood in cases with severe disease compared
to mild and moderate disease. RSV positive patients
had higher neonatal TRECs compared to controls, but
there were no differences between disease severity groups
at birth.
Differentiation between severe disease and moderate
disease was based on treatments given, which are objective
end-points. Differentiation between mild and moderate
groups was based on an assessment of respiratory distress
on admission. Follow up assessment of respiratory distress
during admission may have identified patients in the mild
Fig. 1 TREC and lymphocyte counts in infants with active Respiratory syncytial virus disease, by disease severity. Note: Panels a and b: T-cell
receptor excision circle (TREC) copy numbers and lymphocyte counts in peripheral blood according to disease severity. TREC counts are significantly
lower in the severe disease group. Lymphocyte counts show a similar pattern, but this is not significant. Plots show mean counts with 95% confidence
intervals. Panel c: Scatterplot of TREC vs. lymphocyte counts. There is a strong positive correlation between TREC counts and lymphocyte
counts (p = 0.00001; R2 = 0.371). Panel d: Because TREC counts were strongly correlated to lymphocyte counts, and lymphocyte counts showed a similar
pattern to TRECs between groups, TREC counts were adjusted for lymphocytes using ANCOVA. Estimated marginal means with 95% confidence intervals
for TREC copies are presented. The difference in TREC count between disease severities remains significant. Post-hoc testing identified the severe disease
group as having a lower adjusted TREC count than mild and moderate disease subgroups (p= 0.07 and p = 0.007, respectively). There was no difference
between mild and moderate groups
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group who qualified for the moderate group. There may
also be some overlap between mild disease cases and
controls. Controls did not present to paediatric units in
our region and the general practitioner of these patients
did not send a nasopharyngeal aspirate for RSV detec-
tion. However, almost all children are exposed to RSV
by age two years and it is therefore highly likely that
controls have also been exposed to RSV, but had a mild
course of infection [2].
RSV positive children during acute illness
We found lower TREC counts in the whole blood of
severe RSV patients, but no significant difference in
lymphocyte levels. The literature suggests several mecha-
nisms that might explain reduced TREC counts in severe
RSV disease: i) reduced thymic activity, ii) increased
lymphocyte apoptosis, or iii) redistribution of lymphocytes
to other tissues than peripheral blood. Glucocorticoid-
mediated thymic suppression is associated with stress
[16], which is more likely in severe disease. This concurs
with previous studies reporting decreased lymphocytes
associated with severe stress in septic patients and after
cardiac bypass [17]. Previously published studies report a
reduction in absolute lymphocyte counts in children with
acute RSV, with most pronounced effects in children who
require intensive care [17]. Depletion of T-lymphocyte
activity has been associated with mechanical ventilation
[18] and a longer duration of oxygen supplementation in
infants with RSV infection [19]. The symptoms and signs
of RSV disease in our patients varied. Only a few received
intensive care and none were ventilated. This patient
cohort is therefore representative for the great majority
of RSV positive patients presenting to hospital, but not
for those with the most severe forms of RSV infection.
This may explain the discrepancy between our study
and previous reports. A study of peripheral blood during
RSV infection did not find differences in T-lymphocyte
cytokines between disease severity groups, but lymphocytes
had a reduced lymphoproliferative response on stimulation
with phytohaemagglutinin [20].
Increased lymphocyte apoptosis in patients with acute
RSV infection was suggested in a study by Roe et al. [21]
in which expression of the apoptosis-promoting proteins
Fas and tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL) receptor on CD4+ and CD8
+T-cells during the acute phase was upregulated com-
pared to recovery phase samples [17]. Finally, redistri-
bution of peripheral blood lymphocytes to the lungs
during RSV disease was reported [22], and was most
pronounced in severe disease. This is in contrast to
our study, as lymphocyte levels were not significantly
lower in severe disease, which may reflect the paucity
of patients requiring mechanical ventilation.
Our study took advantage of samples already available in
a biobank and therefore had several limitations. It would
have been useful to measure other markers of lymphocyte
activity, and to differentiate between T-lymphocytes,
including T-lymphocyte subtypes, and B-lymphocytes.
In our study, blood samples were taken on presenta-
tion to hospital, in many cases before the need for oxy-
gen supplementation arose (median SpO2 94.7% on
admission in the severe disease group, see Table 1), and
compared to other studies no patients were mechanically
ventilated. TREC might therefore be a more sensitive
biomarker for disease severity than cytokines, lymphocyte
levels or lymphocyte responses. Further studies could
investigate TREC’s potential to guide clinical decisions.
Neonatal DBS filter cards from patients and controls
Evaluation of the immune system prior to infection is
particularly interesting, because it may uncover defi-
ciencies that predispose infants to more severe disease.
Fig. 2 TREC counts in neonatal screening cards in infants who later
test positive for Respiratory syncytial virus (RSV), compared to infants
who do not. Note: Values shown are mean neonatal TREC copies with
95% confidence interval in neonatal dried blood spot filter cards for 85
RSV positive patients and 47 controls. Panel a: infants later testing
positive for RSV have significantly higher TREC counts compared to
controls. Panel b: no significant difference was found between the
disease severity subgroups. On post-hoc testing, mild and severe
disease subgroups, but not the moderate subgroup, were significantly
different to controls. *Post-hoc comparison of each disease subgroup
to control, using Dunnett’s test
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In this study we find higher neonatal TREC counts at
birth in patients compared to controls. RSV disease
severity is thus not associated with reduced thymic
activity at birth, and patients are unlikely to carry a
congenital T-cell defect. Increased TREC numbers may
nevertheless reflect an immature adaptive immune
system.
TREC counts increase on production of TREC positive
naive T-cells by the thymus, and decrease on cell death
or on dilution during peripheral division of the T-cell
pool [4, 23]. High TREC levels in our patients may result
from a normal continuous thymic output and reduced
peripheral expansion of the naive T-cell pool [17]. We
have previously published in a prospective study evi-
dence that IL7R gene is down regulated in cord blood of
patients later diagnosed with RSV infection [24]. Our
present findings concur with these results. Cytokines,
most importantly IL-7, has a crucial role in proliferation
and survival of the naive T-cell pool [17]. Reduced IL-7R
expression causes lower proliferation of naive T-cells.
The overall effect may therefore be that neonates who
later present to hospital with RSV have a greater propor-
tion of naïve lymphocytes in their peripheral blood com-
pared to other neonates, and reduced peripheral
expansion of lymphocytes carrying RSV-antigen recep-
tors. We propose that reduced peripheral expansion or
prolonged naive T-cell survival may delay the adaptive
immune response, allowing prolonged viral replication
and a greater innate inflammatory response, both factors
associated with increased disease severity [25–28].
Conclusion
In acute RSV disease, we found lower TREC counts in
infants with severe disease, suggesting that it has poten-
tial as a biomarker for severe disease. We found higher
TREC numbers in neonatal DBS filter cards in patients
than in controls, suggesting that patients later diagnosed
with RSV do not have reduced thymus activity from
birth and probably no congenital T-cell defect.
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